AU2001279933A1 - Use of quinoline-2(1h)-one derivatives for treating renal disease - Google Patents

Use of quinoline-2(1h)-one derivatives for treating renal disease

Info

Publication number
AU2001279933A1
AU2001279933A1 AU2001279933A AU7993301A AU2001279933A1 AU 2001279933 A1 AU2001279933 A1 AU 2001279933A1 AU 2001279933 A AU2001279933 A AU 2001279933A AU 7993301 A AU7993301 A AU 7993301A AU 2001279933 A1 AU2001279933 A1 AU 2001279933A1
Authority
AU
Australia
Prior art keywords
quinoline
derivatives
renal disease
treating renal
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001279933A
Inventor
Philip Janiak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU2001279933A1 publication Critical patent/AU2001279933A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001279933A 2000-08-01 2001-07-31 Use of quinoline-2(1h)-one derivatives for treating renal disease Abandoned AU2001279933A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0010136A FR2812548B1 (en) 2000-08-01 2000-08-01 USE OF QUINOLEIN-2 (1H) -ONE DERIVATIVES OR ONE OF THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF KIDNEY DEFICIENCY
FR0010136 2000-08-01
PCT/FR2001/002493 WO2002009712A1 (en) 2000-08-01 2001-07-31 Use of quinoline-2(1h)-one derivatives for treating renal disease

Publications (1)

Publication Number Publication Date
AU2001279933A1 true AU2001279933A1 (en) 2002-02-13

Family

ID=8853192

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001279933A Abandoned AU2001279933A1 (en) 2000-08-01 2001-07-31 Use of quinoline-2(1h)-one derivatives for treating renal disease

Country Status (3)

Country Link
AU (1) AU2001279933A1 (en)
FR (1) FR2812548B1 (en)
WO (1) WO2002009712A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK167187A (en) * 1986-04-02 1987-10-03 Otsuka Pharma Co Ltd CARBOSTYRIC DERIVATIVES AND SALTS THEREOF, PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS AND MEDICINAL CONTAINING THESE
AU683697B2 (en) * 1993-10-21 1997-11-20 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative for inhibiting production of interleukin-8
BR9610579A (en) * 1995-09-15 1999-07-06 Sanofi Synthelabo Quinoline-2 (1H) -one derivatives as serotonin antagonists

Also Published As

Publication number Publication date
FR2812548A1 (en) 2002-02-08
FR2812548B1 (en) 2002-09-20
WO2002009712A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
HK1091495A1 (en) Pyrimidin-5(1h)-one derivatives
PL357634A1 (en) Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
PT1650203E (en) Process of preparation of benzimidazol-2-yl quinolinone derivatives
AU2001282875A1 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2001284646A1 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease
IL229160B (en) Rapamycin derivatives for treatment of solid tumors
GB9904103D0 (en) Quinoline derivatives
TW450031U (en) Trousers of convenience
HRP20040350A2 (en) NOVEL ?-PHENYL-α-OXYSUBSTITUTED PROPIONIC DERIVATIVES: PROCESS FOR ITS PREPARATION AND THEIR US COMPOUNDS
IL146579A0 (en) Process for the preparation of herbicidal derivatives
HUP0105407A3 (en) Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
AU1224802A (en) 1-(alkyl), 1-((heteroaryl)alkyl) and 1-((aryl)alkyl)-7- pyridinyl-imidazo(1,2-a)pyrimidin-5(1H)-one derivatives
AU2001284763A1 (en) Preparation of risperidone
IL149534A0 (en) Preparation of 3-substituted-4-arylquinolin-2-one derivatives
HUP0300703A3 (en) Process for the preparation of quinoline derivatives
AU2001279933A1 (en) Use of quinoline-2(1h)-one derivatives for treating renal disease
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
AU2001232342A1 (en) Processes for preparing quinoline derivatives and intermediates thereof
AU2001258718A1 (en) An improved process for the preparation of quinolone derivatives
NO20014383L (en) Process for Preparation of Cyclo- (Asp-DPhe-NMeVal-Arg-Gly)
AU2002210816A1 (en) Process for preparation of beta-phenethylamine derivative
AU2184202A (en) Imidazolone derivatives for the treatment of viral diseases
AU6947900A (en) Methods of use of fluoroquinolone compounds against bacteria